This study investigated the involvement of Gremlin2 (GREM2), an inhibitor of BMP signaling, particularly the BMP signaling essential for bone formation, in meningioma growth, senescence, and calcification via tryptophan metabolism. Here, GREM2 is linked to meningioma.